Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus

NCT00709475 · clinicaltrials.gov ↗
COMPLETED
Status
747
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novo Nordisk A/S